ASND: Ascendis Pharma A/S Company Projected Revenue

Ascendis Pharma A/S (ASND) develops innovative therapies for metabolic disorders, utilizing the TransCon platform to create long-acting medicines. The revenue forecast demonstrates the company's resilience, where the 0.99 level represents the current value. High patent barriers and strict FDA oversight protect the business, while diversified supply chains in the US and Europe guarantee stable drug deliveries.

Company Projected Revenue: Ascendis (ASND) for 07/04/2022 - 11/14/2026

Analytical breakdowns and data insights for company Ascendis Pharma AS (ASND)

- stock quotes and analyst forecast:

Stock Price Ascendis Pharma A/S|ASND - Price Target Chart

- market capitalization information:

Market Value Ascendis Pharma AS|ASND - Total Enterprise Value

- balance sheet equity data:

Net Assets per Single Share Ascendis Pharma|ASND - Company Book Value|Market Capitalization to Book Value Ratio ascendispharma.com|ASND - Company Total Asset Base

- debt level and financial liquidity data:

- company profitability and valuation multiples indicators:

ASND - Net Income|Projected Future Earnings Ascendis Pharma A/S|ASND - Market Cap to Earnings|Future Price to Earnings Ascendis Pharma|ASND - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Ascendis Pharma AS|ASND - Operating profit before amortization|Net earnings per share (EPS TTM) Ascendis Pharma|ASND - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months ascendispharma.com|ASND - Expected net earnings per share growth this year|Expected earnings per share growth for next year Ascendis Pharma A/S

- issuer revenue and sales details:

ASND - Company Sales Revenue|Company Projected Revenue Ascendis Pharma A/S|ASND - Price-to-Sales Ratio|Forward P/S Multiple Ascendis Pharma AS

Fundamental company analysis:Ascendis Pharma A/S

Signature product of Ascendis Pharma Inc.

Driven by patents for long-acting hormones and a lack of competitors, Ascendis Pharma A/S (ASND) possesses significant pricing power that directly impacts cash flows. This indicator aggregates revenue expectations, accounting for macroeconomic demand and premium product positioning, which allows for an assessment of risks regarding business deviation from a sustainable yield range via the company's projected sales volume.

Analysis of competing companies